Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays

Written by Yiran Gan
Changes in Plasma Biomarkers Differentiate Clinical Stages of Alzheimer's Disease Using Immunomagnetic Reduction Assays - Chao et al. 2024

Changes in Plasma Biomarkers Differentiate Clinical Stages of Alzheimer's Disease Using Immunomagnetic Reduction Assays

Publication Date: 2024.11.1

Authors: Shu-Ping Chao, Wei-Che Lin, Cheng-Hsien Lu, Hsiu-Chuan Wu, Hsing-Cheng Liu, and Chaur-Jong Hu

Journal: Journal of Alzheimer's Disease. 2024;0(0)

© 2024 Chao, Lin, Lu, Wu, Liu and Hu

Journal of Alzheimer's Disease - IOS Press

Yiran Gan
Previous

Association of Rapidly Elevated Plasma Tau Protein With Cognitive Decline in Patients With Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
Next

Theoretical Explorations of Reductions in The Alternative-current Magnetic Susceptibility of Reagent in Immunomagnetic Reduction Assay